In this study we evaluated in mouse liver the effects of cocoa on PPARα signaling. To this aim, mouse diet was supplemented with 10%, w/w, cocoa for one and two weeks. We quantified the expression of PPARα target genes and PPARα gene level and some parameters related to PPARα activation (hepatosomatic index, peroxisomal β-oxidation system and catalase activity). Moreover, we evaluated antioxidant capacity of cocoa by detecting the expression of CAT and SOD1 genes (known to be involved in oxidative balance) and hypolipidemic properties on serum triglycerides. We made a parallel treatment with 0.025%, w/w, ciprofibrate, a well-known PPARα activator, to quantify signal modulation by cocoa. It is known that PPARα activation by ciprofibrate is mediated by direct binding to the receptor and strongly induces expression of target genes. Our results show that cocoa weakly up-regulates PPARα target genes as a consequence of the modulation of the PPARα gene level and does not improve the triglyceride profile in blood. Finally, cocoa increased SOD1 gene expression suggesting an antioxidant effect.
Chocolate consumption has been associated with improvement in blood pressure (BP) [1] [2] [3] , insulin sensitivity [1] and cholesterol level [3] . Furthermore, a recent study showed that a more frequent chocolate intake is connected with a lowering of the body mass index (BMI), in opposition to associations presumed based on calories alone [4] .
Chocolate and cocoa products are processed food from cocoa beans, seeds of Theobroma cacao L. They are rich in polyphenols, which have antioxidant properties and could contribute to favorable relationships of chocolate consumption to metabolic factors. Numerous polyphenolic compounds are present in cocoa beans, but flavonoids are the main polyphenolic subclass in cocoa powder. Flavan-3-ols, catechin and epicatechin (monomeric units), and proanthocyanidins (polymeric compounds comprising catechin and epicatechin subunits) are primary flavonoids in cocoa and chocolate. For example, cocoa powder can contain as much as 10% flavonoids on a dry-weight basis [5] .
Experiments carried out on mice have demonstrated that catechins from tea have the potential to influence body fat accumulation by stimulating fat oxidation trough up-regulation of the β-oxidation pathway. The expression of many lipid-metabolizing enzymes, including ACO involved in the β-oxidation pathway, is transcriptionally regulated by peroxisome proliferator-activated receptor α (PPARα). Interestingly, catechins are not ligands for PPARα and the precise molecular mechanism by which they stimulate lipid metabolism is not well established at present [6] . In peroxisome, degradation of very long fatty acids is performed by the β-oxidation pathway and is coupled to hydrogen peroxide production (a molecule classified as a reactive oxygen species, ROS), which is generally degraded by catalase. Drugs, or specific conditions (like fasting) that induce fatty acid catabolism in peroxisome can determine hydrogen peroxide accumulation and increase oxidative stress [7] .
The present study was designed to examine the effects of cocoa on the PPARα signaling pathway. Therefore, via a two-week highcocoa diet in a mouse model, this study addressed whether, in liver, cocoa could active gene expression related to PPARα. Moreover, we evaluated the expression of catalase and SOD1 gene, to investigate a possible role of cocoa on oxidative stress in our model, and evaluated the triglyceride profile in blood. Finally, data collected were compared with those obtained with a parallel treatment with ciprofibrate, a well-known PPARα activator.
A previous study showed the ability of catechins from tea to stimulate in mouse liver the expression of many lipid-metabolizing enzymes, including ACO involved in the β-oxidation system, independently from PPARα [6] . Here, we examine and compare the effects of cocoa (rich in catechins) and ciprofibrate (a well-known PPARα activator) on the PPARα signaling pathway.
PPARα agonists, globally known as peroxisome proliferators (PPs), comprise a wide range of substances, including therapeutic agents (such as ciprofibrate), industrial chemicals, environmental pollutants, and endogenous compounds, like natural fatty acids [7, 8] .
Depending on cell and agonist type, PPARα is involved in many metabolic functions and cellular processes, such as proliferation, differentiation, survival, cancer and apoptosis [9] . In mice liver, the first hallmark of PPARα signaling pathway activation by PPs is peroxisome proliferation (i. e. increase in peroxisome volume and number) and is associated with marked induction of fatty acyl-CoA oxidase, which is the peroxide-generating enzyme involved in the peroxisomal β-oxidation pathway [7, 10, 11] . Furthermore, PPARα activation determines hepatic cell proliferation and inhibition of apoptosis in mice, causing either liver enlargement after short-time treatment, or hepatocarcinoma after long-time treatment [7, 12, 13] .
In our experimental model, the hepato-somatic index (HSI) (i.e., liver weight as a percent of body weight) increased during ciprofibrate administration (named Cip), reaching about 190% that Table 1 ). This was in agreement with our previous data collected for the same treatment in different rodent models [8, 14] . Cocoa treatment for one or two weeks (named C 1w and C 2w, respectively) did not affect HSI. Triglycerides hematic contents and biochemical activities of the peroxisomal β-oxidation system and catalase did not change under cocoa treatment. On the contrary, ciprofibrate modified significantly the above-mentioned parameters (peroxisomal β-oxidation system: 213%; catalase: 267%, triglyceride contents: -57%; P<0.01) ( Tables 1 and 2 ). Though these data could suggest that PPARα is not activated under cocoa treatment, we could not exclude that there may be a mild activation of the receptor. To go a step forward, we determined the mRNA expression of some genes involved in the PPARα signaling pathway. PPARα activation increases the expression of some specific genes, named PPARα target genes. These genes present, in their promoter, a specific sequence, known as Peroxisome Proliferator Response Element (PPRE) and their modulation in response to PPARα activation is well reported in the literature [15] . We detected the levels of the following genes: Cyp4a10 (cytochrome P450 4A10), PDK4 (mitochondrial pyruvate dehydrogenase lipoamide kinase isozyme 4) and AOXI (peroxisomal acyl-CoA oxidase). All three PPARatarget genes examined, Cyp4a10, PDK4 and ACOXI, were induced to different extents both by ciprofibrate (about 750-, 320-and 16-fold, respectively, P<0.01) and by cocoa (about 32-, 9-and 2.6-fold, respectively, P<0.05, after two weeks of treatment) (Figure 1 ). In general, the up-regulation of the mentioned PPARα target genes and the increase in peroxisomal enzyme activity and HSI examined above are associated. In this case, we can argue that cocoa moderately activates PPARα signaling, determining only a weak mRNA modulation of the considered genes.
The most abundant phytochemicals in chocolate are catechins. As mentioned, catechins (from tea) are able to modulate the PPARα driven pathway without direct receptor binding [6] . We observed that PPARα-mRNA levels in mice liver were increased by about 1.7-and 2.6-fold after one and two weeks of cocoa administration (P<0.05), respectively, and about 1.4-fold after ciprofibrate treatment (not significant) (Figure 1 ). The rising amount of mRNA-PPARα could correspond to higher and higher levels of protein, which, in turn, could amplify the effects of endogenous agonists justifying the independent receptor modulation of PPARα signaling.
Finally, we detected the mRNA level of CAT and SOD1, two enzymes involved in oxidative stress (Figure 1 ). Neither cocoa nor ciprofibrate induced changes in CAT-mRNA levels, while SOD1-mRNA was strongly induced (about 3.2-fold, P<0.05) after 2-weeks treatment with cocoa, suggesting a protective role of cocoa against oxidative stress.
In this work we evaluated and compared the effects of cocoa and ciprofibrate on PPARα signaling in mouse liver. Ciprofibrate, acting by direct binding to PPARα, produced strong up-regulation of PPARα target genes (without affecting its own level of expression), reduced the lipid content of serum, changed the hepatosomatic index (HSI), and the activities of the peroxisomal β-oxidation system and catalase. Conversely, cocoa weakly reduced mRNA levels PPARα target, did not vary triglyceride contents in blood and strongly up-regulated SOD1 gene expression. The properties of cocoa could be ascribed to its catechin content. Murase et al. [6] showed that catechins from tea activate PPARα without direct binding to the receptor. Our results suggest a different mode-of-action from ciprofibrate PPARα activation: catechins in cocoa could raise the PPARα gene expression. This may correspond to an increase in protein and the augmented content of PPARα protein could amplify the role of the endogenous PPARα ligands, producing an up-regulation of PPARα target genes. For the first time, to our knowledge, we have shown that cocoa is able to modulate PPARα signaling indirectly by up-regulation of PPARα gene expression. 
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Natural Product Communications Vol. 8 (5) 2013 581 Table 1 : HSI, peroxisomal β-oxidation system and catalase specific activities. HSI, peroxisomal β-oxidation system and catalase specific activities: N, control; C 1w and C 2w, animals with 10% cocoa powder added to their chow for 1 and 2 weeks, respectively; Cip, animals treated with standard diet containing 0.025%, w/w, ciprofibrate for 1 week. HSI, hepato-somatic index, i. e., liver weight as a percent of body weight; β-oxidation system (SA), β-oxidation system specific activity, mU/mg of proteins; catalase SA, catalase specific activity, U/mg of proteins. ** Significantly different from N group, P< 0.01 Diet was prepared by mixing 10%, w/w, cocoa with triturated Purina chow. The ciprofibrate diet was prepared as already reported [14] .
Animals:
Animal studies were performed in compliance with European Community specifications regarding the use of laboratory animals. Swiss mice, about 35 g in weight, were kept at 20-22°C with a 12-h light/12-h dark cycle, then were randomly divided into 4 experimental groups and fed with different types of diet. The groups were N (control), C 7 (animals treated for 1 week with a 10% cocoa powder enriched diet) C 14 (animals treated for 2 weeks with a 10% cocoa powder enriched diet) and CIP 7 (animals fed for 1 week with the standard diet containing 0.025%, w/w, ciprofibrate (generous gift of SANOFI-WINTHROP, Guildford, UK). After anesthesia with 500 mg/kg of chloral hydrate, blood samples were collected from the heart and immediately tested for triglycerides content using multiCare-in apparatus according to the producer's instructions; the animals (5 for each experiment) were then sacrificed and the livers immediately excised, weighed, and some pieces were frozen in liquid nitrogen for PCR assay, while the residual part (used for enzyme assay) was homogenized (30%, w/v) in cold 10 mM Tris-HCl buffer pH 7.4, containing 0.25 M sucrose, 1 mM ethylendiaminetetracetate, 1mM EDTA (sodium salt), 0.1% ethanol, 0.2 mM dithiothreitol and 0.2 mM phenylmethylsulfonyl fluoride, in a Thomas homogenizer, filtered through two layers of surgical gauze and frozen under nitrogen. Protein concentration was determined by the Lowry method [16] , using BSA as a standard. Catalase activity was assayed according to Lück [17] . The cyanideinsensitive fatty acid β-oxidation system (Box) was assayed according to Bronfmann et al. [18] . Enzymatic activities are given as specific activity, i.e. mU/mg of protein.
Isolation of total RNA and RT-PCR: Analysis of expression of mRNA was made by RT-PCR amplification with respect to housekeeping gene GAPDH. Total RNA was extracted by using the SV Total Isolation RNA kit (SV Total RNA Isolation; Promega, Italy). RNA quality isolation was assessed by A260/A280 ratio. RNA was stored at -70°C. First-strand cDNA was transcribed from 2 µg RNA using random hexamer and MVL RT (Promega). Synthesized cDNA corresponding to 25 ng total RNA and SYBR Green Taq were used for amplification. Specific primers used in PCR reaction were as follows:
